These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 21515053)

  • 21. Synthesis and antioxidant properties of novel N-H and N-substituted propanamide derivatives.
    Olgen S; Kiliç Z; Ada AO; Coban T
    Arch Pharm (Weinheim); 2007 Mar; 340(3):140-6. PubMed ID: 17315261
    [TBL] [Abstract][Full Text] [Related]  

  • 22. New generation dopaminergic agents. 6. Structure-activity relationship studies of a series of 4-(aminoethoxy)indole and 4-(aminoethoxy)indolone derivatives based on the newly discovered 3-hydroxyphenoxyethylamine D2 template.
    Mewshaw RE; Webb MB; Marquis KL; McGaughey GB; Shi X; Wasik T; Scerni R; Brennan JA; Andree TH
    J Med Chem; 1999 Jun; 42(11):2007-20. PubMed ID: 10354409
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor.
    Grundt P; Carlson EE; Cao J; Bennett CJ; McElveen E; Taylor M; Luedtke RR; Newman AH
    J Med Chem; 2005 Feb; 48(3):839-48. PubMed ID: 15689168
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Calcitonin gene-related peptide (CGRP) receptor antagonists: pyridine as a replacement for a core amide group.
    Luo G; Chen L; Civiello R; Pin SS; Xu C; Kostich W; Kelley M; Conway CM; Macor JE; Dubowchik GM
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2917-21. PubMed ID: 22429470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and synthesis of novel and potent amide linked PPARgamma/delta dual agonists.
    Shi Q; Canada EJ; Xu Y; Warshawsky AM; Etgen GJ; Broderick CL; Clutinger CK; Irwin LA; Laurila ME; Montrose-Rafizadeh C; Oldham BA; Wang M; Winneroski LL; Xie C; York JS; Yumibe NP; Zink RW; Mantlo N
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6744-9. PubMed ID: 18029178
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of dihydrobenzofuran amides as orally bioavailable, centrally active γ-secretase modulators.
    Pettersson M; Johnson DS; Subramanyam C; Bales KR; am Ende CW; Fish BA; Green ME; Kauffman GW; Lira R; Mullins PB; Navaratnam T; Sakya SM; Stiff CM; Tran TP; Vetelino BC; Xie L; Zhang L; Pustilnik LR; Wood KM; O'Donnell CJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2906-11. PubMed ID: 22429469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Synthesis and biological activity of 2-[(substituted phenyl)vinyl] indole derivatives].
    Xu L; Xu SP
    Yao Xue Xue Bao; 2001 Feb; 36(2):100-4. PubMed ID: 12579873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based design, synthesis, and structure-activity relationship studies of novel non-nucleoside adenosine deaminase inhibitors.
    Terasaka T; Kinoshita T; Kuno M; Seki N; Tanaka K; Nakanishi I
    J Med Chem; 2004 Jul; 47(15):3730-43. PubMed ID: 15239652
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 1,7-Disubstituted oxyindoles are potent and selective EP(3) receptor antagonists.
    Zhou N; Polozov AM; O'Connell M; Burgeson J; Yu P; Zeller W; Zhang J; Onua E; Ramirez J; Palsdottir GA; Halldorsdottir GV; Andresson T; Kiselyov AS; Gurney M; Singh J
    Bioorg Med Chem Lett; 2010 Apr; 20(8):2658-64. PubMed ID: 20303752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and structure-activity relationship of the isoindolinyl benzisoxazolpiperidines as potent, selective, and orally active human dopamine D4 receptor antagonists.
    Hendrix JA; Shimshock SJ; Shutske GM; Tomer JD; Kapples KJ; Palermo MG; Corbett TJ; Vargas HM; Kafka S; Brooks KM; Laws-Ricker L; Lee DK; de Lannoy I; Bordeleau M; Rizkalla G; Owolabi J; Kamboj RK
    Chembiochem; 2002 Oct; 3(10):999-1009. PubMed ID: 12362366
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a novel indole series of EP1 receptor antagonists by scaffold hopping.
    Hall A; Billinton A; Brown SH; Chowdhury A; Giblin GM; Goldsmith P; Hurst DN; Naylor A; Patel S; Scoccitti T; Theobald PJ
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2684-90. PubMed ID: 18378447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a new class of potent, selective, and orally bioavailable CRTH2 (DP2) receptor antagonists for the treatment of allergic inflammatory diseases.
    Crosignani S; Page P; Missotten M; Colovray V; Cleva C; Arrighi JF; Atherall J; Macritchie J; Martin T; Humbert Y; Gaudet M; Pupowicz D; Maio M; Pittet PA; Golzio L; Giachetti C; Rocha C; Bernardinelli G; Filinchuk Y; Scheer A; Schwarz MK; Chollet A
    J Med Chem; 2008 Apr; 51(7):2227-43. PubMed ID: 18318469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design, synthesis, and biological evaluation of novel diarylalkyl amides as TRPV1 antagonists.
    Li FN; Kim NJ; Paek SM; Kwon DY; Min KH; Jeong YS; Kim SY; Park YH; Kim HD; Park HG; Suh YG
    Bioorg Med Chem; 2009 May; 17(10):3557-67. PubMed ID: 19398205
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design and synthesis of 4-arylpiperidinyl amide and N-arylpiperdin-3-yl-cyclopropane carboxamide derivatives as novel melatonin receptor ligands.
    Li G; Zhou H; Jiang Y; Keim H; Topiol SW; Poda SB; Ren Y; Chandrasena G; Doller D
    Bioorg Med Chem Lett; 2011 Feb; 21(4):1236-42. PubMed ID: 21237644
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent PPAR-gamma binding agents with potential application to the treatment of osteoporosis.
    Hopkins CR; O'neil SV; Laufersweiler MC; Wang Y; Pokross M; Mekel M; Evdokimov A; Walter R; Kontoyianni M; Petrey ME; Sabatakos G; Roesgen JT; Richardson E; Demuth TP
    Bioorg Med Chem Lett; 2006 Nov; 16(21):5659-63. PubMed ID: 16919947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. New 1,2,3,4-tetrahydropyrrolo[3,4-b]indole derivatives as selective CB2 receptor agonists.
    Pagé D; Yang H; Brown W; Walpole C; Fleurent M; Fyfe M; Gaudreault F; St-Onge S
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6183-7. PubMed ID: 17884494
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and serotonergic activity of substituted 2, N-benzylcarboxamido-5-(2-ethyl-1-dioxoimidazolidinyl)-N, N-dimethyltryptamine derivatives: novel antagonists for the vascular 5-HT(1B)-like receptor.
    Moloney GP; Martin GR; Mathews N; Milne A; Hobbs H; Dodsworth S; Sang PY; Knight C; Williams M; Maxwell M; Glen RC
    J Med Chem; 1999 Jul; 42(14):2504-26. PubMed ID: 10411472
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Heterocyclic 1,7-disubstituted indole sulfonamides are potent and selective human EP3 receptor antagonists.
    Hategan G; Polozov AM; Zeller W; Cao H; Mishra RK; Kiselyov AS; Ramirez J; Halldorsdottir G; Andrésson T; Gurney ME; Singh J
    Bioorg Med Chem Lett; 2009 Dec; 19(23):6797-800. PubMed ID: 19836233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Indolyl and dihydroindolyl N-glycinamides as potent and in vivo active NPY5 antagonists.
    Wu L; Lu K; Packiarajan M; Jubian V; Chandrasena G; Wolinsky TC; Walker MW
    Bioorg Med Chem Lett; 2012 Mar; 22(6):2167-71. PubMed ID: 22361135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.
    Brudeli B; Moltzau LR; Andressen KW; Krobert KA; Klaveness J; Levy FO
    Bioorg Med Chem; 2010 Dec; 18(24):8600-13. PubMed ID: 21075638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.